Session information

Oral Presentation

[31-412-am] Intracellular signaling 2

Sun. Mar 31, 2024 8:30 AM - 9:30 AM [Room 412] Conference Center 412 (4F)

Chair: Masashi Asai, Shuji Mizumoto

+Add all to schedule

8:30 AM - 8:42 AM

[31-412-am01] Possibility of using intron retention to evaluate depression and Kampo medicines to treat it.

○Norihiro Okada¹, Kenshiro Oshima¹, Akiko Maruko¹, Akinori Nishi², Mariko Sekine¹, Akino Wakasugi¹, Hiroshi Odaguchi¹, Takayuki Hoshino¹, Yoshinori Kobayashi¹ (1. Kitasato University, 2. Tsumura & Co.)

8:42 AM - 8:54 AM

[31-412-am02] Chondroitin sulfate-A regulates osteoblast differentiation via Wnt3a-β-catenin and p53 signaling

○Toshiyasu Koike¹, Satomi Nadanaka¹, Hiroshi Kitagawa¹ (1. Kobe Pharma. Univ.)

8:54 AM - 9:06 AM

[31-412-am03S] Analysis of anti-inflammatory effect of peptides from Major Royal Jelly Protein 3

○Kanade Naito¹, Koki Hatasa¹, Mieko Tsuji¹, Keita Takahashi¹, Tetsuo Koshizuka ¹ (1. Gifu Pharmaceutical Univ.)

9:06 AM - 9:18 AM

[31-412-am04S] Screening of crude drug-derived compounds that inhibit downstream signaling of inflammatory cytokine IFN-γ

○Akihiro Nohara¹, Nana Takahashi¹, Satoru Yokoyama¹, Yue Zhou¹, Hiroaki Sakurai¹ (1. Grad. Sch. Pharm. Sci., Toyama Univ.)

9:18 AM - 9:30 AM

[31-412-am05S] Drug development targeting glioblastoma stem cells using LATS inhibitors

○Yuki Shimada¹, Manami Yamada¹, Yuki Kinoshita², Yuko Ueda¹, Kaori Kitae¹, Yoshihiro Hirade¹, Hiroaki Hase¹, Kentaro Jingushi¹, Kazutake Tsujikawa¹ (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. Sch. Pharm. Sci., Osaka Univ.)